Article
Peroxisome proliferators-activated receptor gamma polymorphisms and colorectal cancer risk.
Journal of cancer research and therapeutics - 1 Jun 2018
Liang Xuemin, Fan Xiaohua, Tan Kanglian, Zhang Li, Jian Lisi, Yu Linchong
Abstract excerpt
AIMS: Several studies evaluated the association between peroxisome proliferators-activated receptor gamma (PPARγ) Pro12Ala (rs1801282), and His477His (rs3856806) polymorphisms and the risk of colorectal cancer (CRC). However, the results were not stable. MATERIALS AND METHODS: We searched databases containing PubMed and EMBASE. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
